Journal article

Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research

Shama Virani, Glauco Baiocchi, David Bowtell, Citadel J Cabasag, Kathleen R Cho, Renee T Fortner, Keiichi Fujiwara, Jae-Weon Kim, Martin Kobel, Jean-Emmanuel Kurtz, Douglas A Levine, Usha Menon, Barbara M Norquist, Paul DP Pharoah, Anil K Sood, Shelley T Tworoger, Nicolas Wentzensen, Stephen J Chanock, Paul Brennan, Britton Trabert



Recently, ovarian cancer research has evolved considerably because of the emerging recognition that rather than a single disease, ovarian carcinomas comprise several different histotypes that vary by etiologic origin, risk factors, molecular profiles, therapeutic approaches and clinical outcome. Despite significant progress in our understanding of the etiologic heterogeneity of ovarian cancer, as well as important clinical advances, it remains the eighth most frequently diagnosed cancer in women worldwide and the most fatal gynecologic cancer. The International Agency for Research on Cancer and the United States National Cancer Institute jointly convened an expert panel on ovarian carcinoma ..

View full abstract


Funding Acknowledgements

International Agency for Research on Cancer (IARC); Division of Cancer Epidemiology and Genetics of the US National Cancer Institute Intramural Research Program.